共 4 条
The Fourth INTERMACS Annual Report: 4,000 implants and counting
被引:307
作者:
Kirklin, James K.
[1
]
Naftel, David C.
Kormos, Robert L.
[2
]
Stevenson, Lynne W.
[3
]
Pagani, Francis D.
[4
]
Miller, Marissa A.
[5
]
Baldwin, J. Timothy
[5
]
Young, James B.
[6
]
机构:
[1] Univ Alabama, Div Cardiovasc, Birmingham, AL 35294 USA
[2] Univ Pittsburgh, Med Ctr, Presbyterian Univ Hosp, Pittsburgh, PA USA
[3] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] NHLBI, Bethesda, MD 20892 USA
[6] Cleveland Clin Fdn, Lerner Coll Med, Cleveland, OH 44195 USA
关键词:
mechanical circulatory support;
ventricular assist devices;
INTERMACS;
advanced heart failure;
destination therapy;
heart failure therapy;
D O I:
10.1016/j.healun.2011.12.001
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
The Fourth Annual Report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 5 years of patient and data collection. With more than 4,000 patients entered into the database, the evolution of pump technology, strategy at implant, and pre-implant patient profiles are chronicled. A risk factor analysis of the entire adult primary implant population is provided, and the recent composition of patient profiles is examined. Current actuarial survival with continuous-flow pumps exceeds 80% at 1 year and 70% at 2 years. J Heart Lung Transplant 2012;31:117-26 (C) 2012 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:117 / 126
页数:10
相关论文